Literature DB >> 3491191

Prediction of death, myocardial infarction, and worsening chest pain using thallium scintigraphy and exercise electrocardiography.

H M Staniloff, J S Forrester, D S Berman, H J Swan.   

Abstract

Although used extensively, there is little published information on the prognostic ability of exercise 201Tl scintigraphy. Accordingly, 1 yr after testing we contacted 819 patients without previous MI or CABG seen in our laboratory during a 2-yr period. Events were defined as death from a cardiovascular cause, nonfatal MI, or worsening clinical state requiring CABG. The event rate was 3.9 events per 100 patients per year. There was univariate prognostic information when comparing the highest and lowest categories as risk ratios for chest pain characteristics (2.7), sex (2.3), exercise duration (3.1), ST slope (2.5), and thallium pattern (11.6), intensity of perfusion defect (17.2), and number of abnormal regions (8.7). However, the strongest predictors were also the least common. Prognostic ability was improved by combining the results categorically, as the number of abnormal tests (13.9). The highest risk ratio, 20.5:1, was obtained by combining results through discriminant function analysis. We conclude that exercise thallium scintigraphy provides prognostic information, although the most predictive patterns are uncommon. Combining the results of multiple test results improves the prognostic ability.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3491191

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  26 in total

1.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

2.  In retroSPECT: the prognostic value of nuclear cardiology-past, present, and future.

Authors:  Dorinna D Mendoza; Manuel D Cerqueira
Journal:  J Nucl Cardiol       Date:  2004 May-Jun       Impact factor: 5.952

3.  Left ventricular shape index assessed by gated stress myocardial perfusion SPECT: initial description of a new variable.

Authors:  Aiden Abidov; Piotr J Slomka; Hidetaka Nishina; Sean W Hayes; Xingping Kang; Shunichi Yoda; Ling-De Yang; James Gerlach; Fatma Aboul-Enein; Ishac Cohen; John D Friedman; Paul B Kavanagh; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-09       Impact factor: 5.952

4.  Predicting therapeutic benefit from myocardial revascularization procedures: are measurements of both resting left ventricular ejection fraction and stress-induced myocardial ischemia necessary?

Authors:  Rory Hachamovitch; Alan Rozanski; Sean W Hayes; Louise E J Thomson; Guido Germano; John D Friedman; Ishac Cohen; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

5.  Prognostic value of myocardial perfusion SPECT versus exercise electrocardiography in patients with ST-segment depression on resting electrocardiography.

Authors:  Andrea De Lorenzo; Rory Hachamovitch; Xingping Kang; Heidi Gransar; Maria G Sciammarella; Sean W Hayes; John D Friedman; Ishac Cohen; Guido Germano; Daniel S Berman
Journal:  J Nucl Cardiol       Date:  2005 Nov-Dec       Impact factor: 5.952

Review 6.  Role of nuclear cardiology for determining management of patients with stable coronary artery disease.

Authors:  R J Gibbons
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

7.  Comparison of the treadmill exercise score and single-photon emission computed tomographic thallium imaging in risk assessment.

Authors:  A S Iskandrian; J Johnson; T T Le; V Wasserleben; V Cave; J Heo
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

8.  American Society of Nuclear Cardiology project on myocardial perfusion imaging: measuring outcomes in response to emerging guidelines.

Authors:  R S Gibbons
Journal:  J Nucl Cardiol       Date:  1996 Sep-Oct       Impact factor: 5.952

Review 9.  Risk assessment in patients with stable coronary artery disease: incremental value of nuclear imaging.

Authors:  D S Berman; R Hachamovitch
Journal:  J Nucl Cardiol       Date:  1996 Nov-Dec       Impact factor: 5.952

10.  What should we expect in a prognosis study in 2012?

Authors:  Rory Hachamovitch
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.